Impact of comorbidity on waiting list and post-transplant outcomes in patients undergoing liver retransplantation.

about

Impact of comorbidity on waiting list and post-transplant outcomes in patients undergoing liver retransplantation.

Item

http://www.wikidata.org/entity/Q41169640

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Impact of comorbidity on waiti ...... going liver retransplantation.

@en

type

Item

label

Impact of comorbidity on waiti ...... going liver retransplantation.

@en

prefLabel

Impact of comorbidity on waiti ...... going liver retransplantation.

@en

P1476

Impact of comorbidity on waiti ...... going liver retransplantation.

@en

P2093

Carl Moran

http://www.w3.org/2001/XMLSchema#string

Julia A Wendon

http://www.w3.org/2001/XMLSchema#string

Kosh Agarwal

http://www.w3.org/2001/XMLSchema#string

Matthew R Foxton

http://www.w3.org/2001/XMLSchema#string

Michael A Heneghan

http://www.w3.org/2001/XMLSchema#string

Mohammad A B Al-Freah

http://www.w3.org/2001/XMLSchema#string

Nigel D Heaton

http://www.w3.org/2001/XMLSchema#string

P2860

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

A prognostic model for predicting survival in cirrhosis with ascites.

Orthotopic liver transplantation for hepatitis C: outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience.

Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score.

Liver retransplantation in adults: a single-centre, 25-year experience

Tacrolimus versus microemulsified ciclosporin in liver transplantation: the TMC randomised controlled trial.

Model for end-stage liver disease (MELD) and allocation of donor livers.

Hepatic Retransplantation--an analysis of risk factors associated with outcome

P304

884-895

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4254/WJH.V9.I20.884

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28804571

http://www.w3.org/2001/XMLSchema#string

P932

5534363

http://www.w3.org/2001/XMLSchema#string